Laboratory diagnostics of systemic autoimmune diseases. Part 1. Collagenoses;Labordiagnostik der systemischen autoimmunerkrankungen: Teil I: Kollagenosen

Zeitschrift fur Rheumatologie

Volumn 65, Issue 8, 2006, Pages 709-724

  Hartung, K ^a   Seelig, H P ^b  

^a Klinikum Bremerhaven Reinkenheide   (Germany)

^b Labor Prof Seelig und Kollegen   (Germany)

Author keywords

ANA; Autoantibodies; Autoimmune disease; Complement; Diagnosis

Indexed keywords

AUTOIMMUNE DISEASE; DIAGNOSTIC VALUE; LABORATORY DIAGNOSIS; PATIENT MONITORING; POLYMYOSITIS; REVIEW; SCLERODERMA; SJOEGREN SYNDROME; SKIN DISEASE;

ANTIBODIES, ANTINUCLEAR; ANTIBODY SPECIFICITY; AUTOANTIBODIES; AUTOIMMUNE DISEASES; COLLAGEN DISEASES; COMPLEMENT SYSTEM PROTEINS; DIAGNOSIS, DIFFERENTIAL; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MASS SCREENING; PREDICTIVE VALUE OF TESTS;

EID: 33845871977     PISSN: 03401855     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00393-006-0125-5     Document Type: Review

References (14)

1. Arbuckle MR, McClain MT, Rubertone MV et al. (2003) Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 349: 1526-1533
2. Conrad K (Hrsg) (1998) Autoantik̈rper. Update: Clinical Immunology, Vol 8. Pabst Science, Lengerich
3. Ehrfeld H, Renz M, Hartung K et al. (1994) Rekombinante Ro-, La und U1-n-RNP-Antigene: Nachweis von Autoantikörpern mittels ELISA und klinische Assoziationen beim SLE. Z Ärztl Fortbild 88: 495-500
4. Font J, Cervera R, Ramos-Casals M et al. (2004) Clusters of clinical and immunologic features in systemic lupus erythematosus: analysis of 600 patients from a single center. Semin Arthritis Rheum 33: 217-230
5. Ho KT, Reveille JD (2003) The clinical relevance of autoantibodies in scleroderma. Arthritis Res Ther 5: 80-93
6. Hoffman IE, Peene I, Meheus L et al. (2004) Specific antinuclear antibodies are associated with clinicaI features in systemic lupus erythematosus. Ann Rheum Dis 63: 1155-1158
7. Koopman WJ (ed) (2005) Arthritis and allied conditions: a textbook of rheumatology. Williams & Wilkins, Baltimore
8. Peter JB, Shoenfeld Y (eds) (1996): Autoantibodies. Elsevier, Amsterdam
9. Porcel JM, Peakman M, Senaldi G, Vergani D (1993) Methods for assessing complement activation in the clinical immunology laboratory. J Immunol Methods 157: 1-9
10. Riemekasten G, Marell J, Trebeljahr G et al. (1998) A novel epitope on the C-terminus of SmD1 is recognized by the majority of sera from patients with systemic lupus erythematosus. J Clin Invest 102: 754-763
11. Tsokos GC (ed) (2004) Complement in autoimmunity. Current directions in autoimmunity, vol 7. Karger, Basel Freiburg New York
12. Wallace DJ, Hahn BH (eds) (2002) Dubois' Lupus Erythematosus, 6th edn. Williams & Wilkins, Baltimore
13. Wiik A (2005) Anti-nuclear antibodies: clinical utility for diagnosis, prognosis, monitoring, and planning of treatment strategy in systemic immunoinflammatory diseases. Scand J Rheumatol 34: 260-268
14. Witte T, Matthias T, Arnett FC et al. and the SLE-Study Group (2000) IgA and IgG autoantibodies against alpha-Fodrin as markers for Sjögren's Syndrome. J Rheumatol 27: 2617-2620